David Veyer to Pandemics
This is a "connection" page, showing publications David Veyer has written about Pandemics.
Connection Strength
0.049
-
Sequential SARS-CoV-2 IgG assays as confirmatory strategy to confirm equivocal results: Hospital-wide antibody screening in 3,569 staff health care workers in Paris. J Clin Virol. 2020 11; 132:104617.
Score: 0.030
-
Nasal Swab Sampling for SARS-CoV-2: a Convenient Alternative in Times of Nasopharyngeal Swab Shortage. J Clin Microbiol. 2020 05 26; 58(6).
Score: 0.007
-
Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel. J Med Virol. 2021 04; 93(4):2196-2203.
Score: 0.002
-
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19. Blood. 2020 11 12; 136(20):2290-2295.
Score: 0.002
-
Thermal inactivation and nucleic acid amplification-based testing for SARS-CoV-2. J Clin Virol. 2020 Oct; 131:104588.
Score: 0.002
-
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020 08 07; 369(6504):718-724.
Score: 0.002
-
COVID-19-Related Collapsing Glomerulopathy in a Kidney Transplant Recipient. Am J Kidney Dis. 2020 10; 76(4):590-594.
Score: 0.002
-
Potential pitfalls of routine SARS-CoV-2 serology for mass screening. J Med Virol. 2020 11; 92(11):2345.
Score: 0.002